Miglustat Treatment May Reduce Cerebrospinal Fluid Levels of the Axonal Degeneration Marker Tau in Niemann–Pick Type C

Introduction: Niemann–Pick disease type C (NPC) is a lysosomal storage disorder that leads to progressive neurodegeneration. The glucosylceramide synthase blocker miglustat is being used to treat NPC, but monitoring of disease progression and treatment response is difficult. NPC patients have elevat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mattsson, Niklas, Zetterberg, Henrik, Bianconi, Simona, Yanjanin, Nicole M., Fu, Rao, Månsson, Jan-Eric, Porter, Forbes D., Blennow, Kaj
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3509856/
https://ncbi.nlm.nih.gov/pubmed/23430872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2011_47
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados